|
Andrej Janež is a Slovenian diabetologist and diabetes researcher. Janež is the Head of Department of Endocrinology, Diabetes and Metabolic Disease at University Medical Centre Ljubljana, Assistant Professor for Internal Medicine at the Medical University Ljubljana, Chairman of the Advances in Diabetes and Insulin Therapy (ADIT) conference,〔(ADIT 2011 Priliminary list of Faculty )〕 member of the advisory board for peroral antidiabetic therapy in Servier Pharma, member for Slovenia in the Diabetes Education Study Group (DESG) at European Association for the Study of Diabetes (EASD), and member of the European advisory board for continuous glucose monitoring system in development for Lifescan. Janež authored numerous articles〔 ==Education== *MD, 1996, School of Medicine, University of Ljubljana *MS, 1998, School of Medicine, University of Ljubljana with thesis »Effects of chromium on blood pressure in humans« *PhD, 2000, Diabetology School of Medicine, University of California, San Diego, with thesis ''Mechanism of glucose transport in insulin resistant 3T3-L1 adipocytes'' *Post doctoral, 2005, Joslin Diabetes Clinic, Boston, study on insulin pump therapy in Type 1 diabetic patients 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Andrej Janež」の詳細全文を読む スポンサード リンク
|